18 F-FDG PET/CT for response evaluation of regional lymph nodes in 97 head and neck squamous cell carcinoma patients: Differences in the predictive value of residual disease after radiotherapy and chemoradiotherapy

Clin Otolaryngol. 2020 Sep;45(5):805-810. doi: 10.1111/coa.13566. Epub 2020 May 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Chemoradiotherapy, Adjuvant / methods
  • Female
  • Fluorodeoxyglucose F18 / pharmacology*
  • Follow-Up Studies
  • Genetic Testing
  • Head and Neck Neoplasms / diagnosis*
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / radiotherapy
  • Humans
  • Lymph Nodes / diagnostic imaging*
  • Lymphatic Metastasis / diagnostic imaging
  • Male
  • Middle Aged
  • Neoplasm, Residual / diagnosis*
  • Positron Emission Tomography Computed Tomography / methods*
  • Radiopharmaceuticals / pharmacology
  • Retrospective Studies
  • Squamous Cell Carcinoma of Head and Neck / diagnosis*
  • Squamous Cell Carcinoma of Head and Neck / secondary
  • Squamous Cell Carcinoma of Head and Neck / therapy

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18